Alastair Greystoke

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

Matthew Krebs, Robert Szczepaniak‐Sloane, Lynsey Priest et al. · Journal of Clinical Oncology · 2011 · 865 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer

Jian-Mei Hou, Matthew Krebs, Lee Lancashire et al. · Journal of Clinical Oncology · 2012 · 843 citations · Full text

Medicine, Cancer Biology, Oncology +17

Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer

Cassandra L. Hodgkinson, Christopher J. Morrow, Yaoyong Li et al. · Nature Medicine · 2014 · 692 citations

Medicine, Molecular Genetics, Oncology +16

Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy

Jianmei Hou, Alastair Greystoke, Lee Lancashire et al. · American Journal Of Pathology · 2009 · 237 citations · Full text

Medicine, Cell Biology, Oncology +14

A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer

Sarah Halford, Gareth J. Veal, Stephen R. Wedge et al. · Clinical Cancer Research · 2023 · 219 citations · Full text

Medicine, Oncology, Pharmacology +10